Digital health is entering a more mature phase in 2026 as consolidation accelerates through targeted M&A, driven by the need for scale, artificial intelligence and pressure from payers, investors say.

Virtual women’s health provider Midi Health has reached unicorn status after raising a $100 million Series D, with investors backing its insurance-covered, direct-to-consumer model. The company is ...

Included Health is launching an alternative health plan centered on primary care, AI support, price transparency and easier navigation.

Hair loss remains an area lacking biotechnology innovation. The drugs currently available are older products offering limited efficacy. Some of them cannot be used by women. Veradermics aims to shake ...

Providers’ rapid adoption of AI is pushing payers to accelerate their own use of administrative AI tools, with health plans looking for ways to keep pace and manage the growing complexity of claims ...

Regeneron Pharmaceuticals is committing $150 million to begin an alliance on a Tessera Therapeutics gene-editing medicine nearing the clinic as a potential treatment for a rare disease that leads to ...

Three-quarters of the nation’s healthcare providers and payers say they have increased their IT spending over the past year, according to a report released Tuesday by Bain & Company and KLAS Research.

Epic’s lawsuit against Health Gorilla is less about one alleged data misuse scheme and more about a deeper fault line in healthcare interoperability: data can move faster than the rules governing it.

Eli Lilly’s cardiometabolic drug portfolio is expanding with newly approved therapies. To meet demand for those therapies and additional products to come, the company is building a new $2.5 billion ...

Women’s health has been historically sidelined – underfunded, underresearched and often misunderstood. While interest and investment around complex women’s health have increased, we’re still a long ...

As the mental health crisis in the U.S. grows, mental health professionals are increasingly struggling due to workforce shortages. More than half of therapists report having feelings of burnout. And ...

Astellas Pharma is far from alone in viewing cancer as a major growth area, but the Japanese drugmaker has specifically identified a type of therapy called targeted protein degradation as one of the ...